NZ260883A - Oral sustained-release medicaments containing morphine - Google Patents

Oral sustained-release medicaments containing morphine

Info

Publication number
NZ260883A
NZ260883A NZ260883A NZ26088394A NZ260883A NZ 260883 A NZ260883 A NZ 260883A NZ 260883 A NZ260883 A NZ 260883A NZ 26088394 A NZ26088394 A NZ 26088394A NZ 260883 A NZ260883 A NZ 260883A
Authority
NZ
New Zealand
Prior art keywords
medicaments containing
oral sustained
containing morphine
release medicaments
release
Prior art date
Application number
NZ260883A
Inventor
Joanne Heafield
Trevor John Knott
Stewart Thomas Leslie
Sandra Therese A Malkowska
Ronald Brown Miller
Derek Allan Prater
Kevin John Smith
Mark Chasin
Paul Goldenheim
Benjamin Oshlack
Frank Pedi
Richard Sackler
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US8624893A priority Critical
Priority to GB9315467A priority patent/GB2281204A/en
Priority to US13350393A priority
Priority to GB9324045A priority patent/GB2284760B/en
Priority to GB9404928A priority patent/GB2287880A/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NZ260883A publication Critical patent/NZ260883A/en

Links

NZ260883A 1993-07-01 1994-06-29 Oral sustained-release medicaments containing morphine NZ260883A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US8624893A true 1993-07-01 1993-07-01
GB9315467A GB2281204A (en) 1993-07-27 1993-07-27 Sustained release morphine compositions
US13350393A true 1993-10-07 1993-10-07
GB9324045A GB2284760B (en) 1993-11-23 1993-11-23 A method of preparing pharmaceutical compositions by melt pelletisation
GB9404928A GB2287880A (en) 1994-03-14 1994-03-14 Production of sustained release compositions

Publications (1)

Publication Number Publication Date
NZ260883A true NZ260883A (en) 1997-06-24

Family

ID=27517199

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ260883A NZ260883A (en) 1993-07-01 1994-06-29 Oral sustained-release medicaments containing morphine

Country Status (1)

Country Link
NZ (1) NZ260883A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518925B2 (en) 2004-06-08 2013-08-27 Euro-Celtique S.A. Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)
US8673355B2 (en) 1997-12-22 2014-03-18 Purdue Pharma L.P. Opioid agonist/antagonist combinations
US8822487B2 (en) 1997-12-22 2014-09-02 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations
US8846091B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US8969369B2 (en) 2001-05-11 2015-03-03 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9271940B2 (en) 2009-03-10 2016-03-01 Purdue Pharma L.P. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
US10258235B2 (en) 2005-02-28 2019-04-16 Purdue Pharma L.P. Method and device for the assessment of bowel function

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936808B1 (en) 1997-12-22 2015-01-20 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations
US8673355B2 (en) 1997-12-22 2014-03-18 Purdue Pharma L.P. Opioid agonist/antagonist combinations
US8822487B2 (en) 1997-12-22 2014-09-02 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations
US9474750B2 (en) 1997-12-22 2016-10-25 Purdue Pharma L.P. Opioid agonist/opioid antagonist/acetaminophen combinations
US9205082B2 (en) 1997-12-22 2015-12-08 Purdue Pharma L.P. Opioid agonist/antagonist combinations
US8932630B1 (en) 1997-12-22 2015-01-13 Purdue Pharma L.P Opioid agonist/antagonist combinations
US9358230B1 (en) 2001-05-11 2016-06-07 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US8969369B2 (en) 2001-05-11 2015-03-03 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9056051B2 (en) 2001-05-11 2015-06-16 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9084729B2 (en) 2001-05-11 2015-07-21 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9161937B2 (en) 2001-05-11 2015-10-20 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9168252B2 (en) 2001-05-11 2015-10-27 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9480685B2 (en) 2001-05-11 2016-11-01 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9511066B2 (en) 2001-05-11 2016-12-06 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9283216B2 (en) 2001-05-11 2016-03-15 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9283221B2 (en) 2001-05-11 2016-03-15 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9345701B1 (en) 2001-05-11 2016-05-24 Purdue Pharma L.P. Abuse-resistant controlled-release opioid dosage form
US9907793B2 (en) 2002-04-05 2018-03-06 Purdue Pharma L.P. Pharmaceutical preparation containing oxycodone and naloxone
US9555000B2 (en) 2002-04-05 2017-01-31 Purdue Pharma L.P. Pharmaceutical preparation containing oxycodone and naloxone
US8846090B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US8846091B2 (en) 2002-04-05 2014-09-30 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US9655855B2 (en) 2002-04-05 2017-05-23 Purdue Pharma L.P. Matrix for sustained, invariant and independent release of active compounds
US8518925B2 (en) 2004-06-08 2013-08-27 Euro-Celtique S.A. Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)
US10258235B2 (en) 2005-02-28 2019-04-16 Purdue Pharma L.P. Method and device for the assessment of bowel function
US9820983B2 (en) 2009-03-10 2017-11-21 Purdue Pharma L.P. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US9271940B2 (en) 2009-03-10 2016-03-01 Purdue Pharma L.P. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Similar Documents

Publication Publication Date Title
EG21123A (en) Conterweinght drug eliminator
SK197792A3 (en) Pharmaceutical agent
ZA9605368B (en) A pharmaceutical formulation
GR3022154T3 (en) Oral-administration forms of a medicament containing pantoprazol
GB9317764D0 (en) Therapeutic compound
HU9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
EP0726771A4 (en) Desferrioxamine oral delivery system
EP0714302A4 (en) Therapeutic compounds
SG49790A1 (en) Stabilised pharmaceutical
PL304557A1 (en) Pharmaceutical preparation
GB9425160D0 (en) Medicaments
IE914317A1 (en) Medicaments
GB9410222D0 (en) Medicaments
GR3032245T3 (en) Medicaments
GB9024365D0 (en) Medicaments
GB9402807D0 (en) Pharmaceutical compounds
GB9217331D0 (en) Pharmaceutical compounds
LTIP702A (en) A slimming pharmaceutical composition
HRP960034A2 (en) Novel pharmaceutical combination
GB8905400D0 (en) Medicaments
AP9200461A0 (en) Medicaments
IE920004A1 (en) Medicaments
GB9012469D0 (en) Medicaments
GB9024366D0 (en) Medicaments
ZA9600124B (en) A pharmaceutical formulation

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired